BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29559170)

  • 1. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
    Venigalla S; Chowdhry AK; Shalowitz DI
    Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
    Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival advantage of lymphadenectomy in endometrial cancer.
    Eggemann H; Ignatov T; Kaiser K; Burger E; Costa SD; Ignatov A
    J Cancer Res Clin Oncol; 2016 May; 142(5):1051-60. PubMed ID: 26746654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Pelvic and Para-Aortic Lymphadenectomy With Survival in Stage I Endometrioid Endometrial Cancer: Matched Cohort Analyses From the National Cancer Database.
    Seagle BL; Kocherginsky M; Shahabi S
    JCO Clin Cancer Inform; 2017 Nov; 1():1-14. PubMed ID: 30657385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
    Farrell R; Dixon SC; Carter J; Webb PM
    Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study.
    Coronado PJ; Fasero M; Baquedano L; Martinez-Maestre MA; Casado A; Vidart JA; Herraiz MA
    Int J Gynecol Cancer; 2014 May; 24(4):703-12. PubMed ID: 24651627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience.
    Volpi L; Sozzi G; Capozzi VA; Ricco' M; Merisio C; Di Serio M; Chiantera V; Berretta R
    Int J Gynecol Cancer; 2019 Feb; 29(2):312-319. PubMed ID: 30718312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
    Cragun JM; Havrilesky LJ; Calingaert B; Synan I; Secord AA; Soper JT; Clarke-Pearson DL; Berchuck A
    J Clin Oncol; 2005 Jun; 23(16):3668-75. PubMed ID: 15738538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma.
    Casarin J; Bogani G; Piovano E; Falcone F; Ferrari F; Odicino F; Puppo A; Bonfiglio F; Donadello N; Pinelli C; Laganà AS; Ditto A; Malzoni M; Greggi S; Raspagliesi F; Ghezzi F
    J Gynecol Oncol; 2020 Sep; 31(5):e64. PubMed ID: 32808495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival impact of lymphadenectomy stratified by nodal metastatic probability in endometrial cancer.
    Koskas M; Fournier M; Luton D; Darai E; Rouzier R
    Ann Surg Oncol; 2014 Jul; 21(7):2376-82. PubMed ID: 24590435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival.
    Bristow RE; Zahurak ML; Alexander CJ; Zellars RC; Montz FJ
    Int J Gynecol Cancer; 2003; 13(5):664-72. PubMed ID: 14675352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
    Cosgrove CM; Cohn DE; Rhoades J; Felix AS
    Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging.
    Menderes G; Azodi M; Schwartz P; Silasi DA
    Int J Gynecol Cancer; 2015 Jan; 25(1):160-5. PubMed ID: 25386859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis.
    Papathemelis T; Scharl S; Kronberger K; Gerken M; Scharl A; Pauer A; Klinkhammer-Schalke M
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2555-2562. PubMed ID: 28840384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
    Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.